- Home
- PYPD vs ANEB Comparison
PYPD vs ANEB Comparison
Compare PYPD & ANEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PYPD
- ANEB
- Stock Information
- Founded
- PYPD 2008
- ANEB 2020
- Country
- PYPD Israel
- ANEB United States
- Employees
- PYPD N/A
- ANEB N/A
- Industry
- PYPD Medical/Dental Instruments
- ANEB Biotechnology: Pharmaceutical Preparations
- Sector
- PYPD Health Care
- ANEB Health Care
- Exchange
- PYPD Nasdaq
- ANEB Nasdaq
- Market Cap
- PYPD 35.3M
- ANEB 39.0M
- IPO Year
- PYPD 2020
- ANEB 2021
- Fundamental
- Price
- PYPD $3.58
- ANEB $1.42
- Analyst Decision
- PYPD Strong Buy
- ANEB Strong Buy
- Analyst Count
- PYPD 5
- ANEB 2
- Target Price
- PYPD $11.40
- ANEB $5.50
- AVG Volume (30 Days)
- PYPD 1.4M
- ANEB 6.4K
- Earning Date
- PYPD 08-13-2025
- ANEB 05-13-2025
- Dividend Yield
- PYPD N/A
- ANEB N/A
- EPS Growth
- PYPD N/A
- ANEB N/A
- EPS
- PYPD N/A
- ANEB N/A
- Revenue
- PYPD N/A
- ANEB N/A
- Revenue This Year
- PYPD N/A
- ANEB N/A
- Revenue Next Year
- PYPD N/A
- ANEB N/A
- P/E Ratio
- PYPD N/A
- ANEB N/A
- Revenue Growth
- PYPD N/A
- ANEB N/A
- 52 Week Low
- PYPD $2.30
- ANEB $0.80
- 52 Week High
- PYPD $4.49
- ANEB $3.08
- Technical
- Relative Strength Index (RSI)
- PYPD 59.00
- ANEB 59.67
- Support Level
- PYPD $3.12
- ANEB $1.32
- Resistance Level
- PYPD $3.75
- ANEB $1.60
- Average True Range (ATR)
- PYPD 0.29
- ANEB 0.14
- MACD
- PYPD 0.01
- ANEB 0.02
- Stochastic Oscillator
- PYPD 69.83
- ANEB 57.81
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.
About ANEB Anebulo Pharmaceuticals Inc.
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction. The product candidate, ANEB-001, is intended to reverse the negative effects of cannabinoid overdose within 1 hour of administration. The signs and symptoms of cannabinoid overdose range from profound sedation to anxiety and panic to psychosis with hallucinations.